Product NDC: | 0904-5959 |
Proprietary Name: | Clindamycin hydrochloride |
Non Proprietary Name: | Clindamycin hydrochloride |
Active Ingredient(s): | 150 mg/1 & nbsp; Clindamycin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-5959 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065061 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090410 |
Package NDC: | 0904-5959-61 |
Package Description: | 100 CAPSULE in 1 BOX, UNIT-DOSE (0904-5959-61) |
NDC Code | 0904-5959-61 |
Proprietary Name | Clindamycin hydrochloride |
Package Description | 100 CAPSULE in 1 BOX, UNIT-DOSE (0904-5959-61) |
Product NDC | 0904-5959 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20090410 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | CLINDAMYCIN HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |